Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $1.15 billion. The enterprise value is $1.08 billion.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANA has 266.37 million shares outstanding. The number of shares has increased by 10.01% in one year.
| Current Share Class | 266.37M |
| Shares Outstanding | 266.37M |
| Shares Change (YoY) | +10.01% |
| Shares Change (QoQ) | +9.26% |
| Owned by Insiders (%) | 6.95% |
| Owned by Institutions (%) | 53.21% |
| Float | 176.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.46.
| Current Ratio | 4.55 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -96.11% and return on invested capital (ROIC) is -35.29%.
| Return on Equity (ROE) | -96.11% |
| Return on Assets (ROA) | -23.90% |
| Return on Invested Capital (ROIC) | -35.29% |
| Return on Capital Employed (ROCE) | -47.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 194 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.63% in the last 52 weeks. The beta is 1.95, so SANA's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +68.63% |
| 50-Day Moving Average | 4.25 |
| 200-Day Moving Average | 3.13 |
| Relative Strength Index (RSI) | 54.61 |
| Average Volume (20 Days) | 4,156,031 |
Short Selling Information
The latest short interest is 33.12 million, so 12.43% of the outstanding shares have been sold short.
| Short Interest | 33.12M |
| Short Previous Month | 31.99M |
| Short % of Shares Out | 12.43% |
| Short % of Float | 18.71% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -190.20M |
| Pretax Income | -234.41M |
| Net Income | -234.41M |
| EBITDA | -176.70M |
| EBIT | -190.20M |
| Earnings Per Share (EPS) | -$0.96 |
Full Income Statement Balance Sheet
The company has $153.05 million in cash and $89.74 million in debt, giving a net cash position of $63.32 million or $0.24 per share.
| Cash & Cash Equivalents | 153.05M |
| Total Debt | 89.74M |
| Net Cash | 63.32M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 195.31M |
| Book Value Per Share | 0.74 |
| Working Capital | 126.25M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$158.35 million and capital expenditures -$501,000, giving a free cash flow of -$158.85 million.
| Operating Cash Flow | -158.35M |
| Capital Expenditures | -501,000 |
| Free Cash Flow | -158.85M |
| FCF Per Share | -$0.60 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SANA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.01% |
| Shareholder Yield | -10.01% |
| Earnings Yield | -20.47% |
| FCF Yield | -13.87% |
Dividend Details Analyst Forecast
The average price target for SANA is $7.83, which is 82.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.83 |
| Price Target Difference | 82.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -9.05% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |